ALFA Filings
Every announcement, straight from the exchange
Every Biocon regulatory approval announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
Biocon received marketing approval from Japan's MHLW for its Pegfilgrastim biosimilar. This approval enhances Biocon's biosimilar portfolio and market access in Japan.
Biocon received Health Canada approval for its Yesintek (ustekinumab) Autoinjector Pen. This new product format expands the company's immunology portfolio in Canada.